Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Diabetes
•
Endocrinology
Will Omnipod 5 work well in patients receiving bursts of corticosteroids or in those on hemodialysis?
Any recommendations for specific pump adjustments for these times?
Related Questions
Can a patient with a PMHx of pancreatic injury or disease (i.e. blunt trauma, recurrent pancreatitis) take a GLP-1 agonist safely in the setting of morbid obesity and type 2 diabetes?
Do you recommend the use of automated insulin delivery systems (such as Control IQ with Tandem insulin pumps) for managing gestational diabetes?
How do you approach the use of metformin in the management of prediabetes for patients who are neither obese nor have a family history of diabetes?
Do you recommend the use of Korlym (Mifepristone) for patients with difficult to control diabetes and evidence of mild endogenous hypercortisolism of unknown source?
How do you manage enfortumab vedotin related DKA that is refractory to standard therapy (insulin, fluids, etc)?
Do patients with advanced chronic kidney disease tend to have falsely high HbA1c or falsely low HbA1c levels?
What are the potential causes for significant discrepancies between predicted A1c by Dexcom CGM and standard serum A1c by lab draw?
Should we recommend SGLT2i initiation at discharge to all patients hospitalized with acute myocardial infarction?
What is the therapeutic role and blood glucose lowering capability of Bromocriptine and Cholestyramine for the treatment of Type 2 diabetes?
When do you recommend screening patients with T2DM for heart failure?